We also demonstrated that ENL reduces cell viability, survival, and NF-κB activity in MDA-MB-231 and MCF-7 cells, models of triple-negative claudin-low and ERα-positive luminal A breast cancer, respectively. This evidence concerns the gene NFKB1 and breast cancer.